# Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections

> **NCT01566643** · PHASE4 · UNKNOWN · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 231 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** RA5-RACM7
- **DRUG:** RA3-RACM7
- **DRUG:** RA7-RACM7

## Key facts

- **NCT ID:** NCT01566643
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 231 (ESTIMATED)
- **Last updated:** 2012-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566643, "Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01566643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*